Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.

Diabetes & metabolism - 1 Apr 2001

Milionis H J, Liberopoulos E N, Elisaf M S

Abstract excerpt

Several pharmacological agents are associated with hyperlipidemia. Tamoxifen is an example of a drug-induced increase of serum triglyceride levels. However, there are only scarce reports on how inborn errors in lipid metabolism as well as secondary dyslipidemias, including diabetes mellitus, influence the hypertriglyceridemic effect of tamoxifen. Herein, we describe a case of a breast cancer patient receiving...

Topics

Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Blood Glucose
Breast Neoplasms
Cholesterol, HDL
Diabetes Complications
Diabetes Mellitus
Female
Humans
Hypertriglyceridemia
Lipoprotein(a)
Middle Aged
Phenotype
Tamoxifen
Triglycerides

Source

Open in PubMed

Identifiers

PMID: 11353883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics